Citations

1. Heston TF (2000). Lead poisoning. In RE Rakel, ed., Saunders Manual of Medical Practice, 2nd ed., pp. 1513–1515. Philadelphia: W.B. Saunders.

2. Pearson HA, Schonfeld DJ (2003). Lead. In CD Rudolph et al., eds., Rudolph's Pediatrics, 21st ed., pp. 368–371. New York: McGraw-Hill.

3. Robertson WO (2004). Lead section of Chronic poisoning: Trace metals and others. In L Goldman, JC Bennett, eds., Cecil Textbook of Medicine, 22nd ed., vol. 1, pp. 92–93. Philadelphia: Saunders.

4. American Academy of Pediatrics (2000). Herbal vitamins, lead poisoning, developmental delay. Pediatrics, 106: 600–602.

5. U.S. Centers for Disease Control (2005). Blood lead levels-United States, 1999–2002. MMWR, 54(20): 513–516.

6. Needleman HL (2002). Management of lead toxicity. In FD Burg et al., eds., Gellis and Kagan's Current Pediatric Therapy, 17th ed., pp. 1051–1052. Philadelphia: W.B. Saunders.

7. Friedrich MJ (2000). Poor children subject to "environmental injustice." JAMA, 283(23): 3057–3058.

8. Aronson JE, et al. (2000). Elevated blood lead levels among internationally adopted children-United States, 1998. JAMA, 283(11): 1417–1418.

9. Long H, Nelson LS (2004). Metals and metalloids. In JE Tintinalli et al., eds., Emergency Medicine, 6th ed., pp. 1146–1153. New York: McGraw-Hill.

10. Wright RO, et al. (2003). Association between iron deficiency and blood lead level in a longitudinal analysis of children followed in an urban primary care clinic. Journal of Pediatrics, 142: 9–14.

11. Canfield RL, et al. (2003). Intellectual impairment in children with blood lead concentrations below 10 µg per deciliter. New England Journal of Medicine, 348(16): 1517–1526.

12. Shannon MW (1998). Lead. In LM Haddad et al., eds., Clinical Management of Poisoning and Drug Overdose, 3rd ed., pp. 767–783. Philadelphia: W.B. Saunders.

13. Centers for Disease Control and Prevention (2000). Recommendations for blood lead screening of young children enrolled in Medicaid: Targeting a group at high risk. MMWR, 49(RR-14): 1–13.

14. U.S. Preventive Services Task Force (2006). Screening for elevated blood lead levels in children and pregnant women. Available online: http://www.ahrq.gov/clinic/uspstf/uspslead.htm.

15. Rhoads GC, et al. (1999). The effect of dust lead control on blood lead in toddlers: A randomized trial. Pediatrics, 103(3): 551–555.

16. Rogan WJ, et al. (2001). The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead. New England Journal of Medicine, 344(19): 1421–1471.

17. Lin JL, et al. (1999). Chelation therapy for patients with elevated body lead burden and progressive renal insufficiency. Annals of Internal Medicine, 130: 7–13.

18. Simon JA, Hudes ES (1999). Relationship of ascorbic acid to blood lead levels. JAMA, 281(24): 2289–2293.

Other Works Consulted

• Kemper AR, et al. (2005). Follow-up testing among children with elevated screening blood lead levels. JAMA, 293(18): 2232–2237.

• Matte TD (1999). Reducing blood lead levels: Benefits and strategies. JAMA, 281(24): 2340–2342.

• Olson KR (2005). Lead section of Poisoning. In LM Tierney et al., eds., Current Medical Diagnosis and Treatment 2005, 44th ed., pp. 1577–1578. New York: McGraw-Hill.

• Rogan WJ, et al. (2001). The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead. New England Journal of Medicine, 344(19): 1421–1426.